Stay updated on BAT2206 vs Stelara in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the BAT2206 vs Stelara in Psoriasis Clinical Trial page.

Latest updates to the BAT2206 vs Stelara in Psoriasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated to announce a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.SummaryDifference2%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has undergone significant content removal regarding a clinical study for BAT-2206 in patients with plaque psoriasis, including detailed descriptions of the study design, inclusion and exclusion criteria, and the principal investigator's name. The only notable addition is a reference to the study's version revision.SummaryDifference41%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check120 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to BAT2206 vs Stelara in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BAT2206 vs Stelara in Psoriasis Clinical Trial page.